EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dialysis Modalities in Liver Cirrhosis with ESKD

Ting-Yu Lin iD, Ming-Tsang Chuang iD, Wei-Yu Kao iD, Hsing-Jung Yeh, Raymond K Hsu iD, Jui-Ting Chang iD, Yen-Chung Lin iD

Kidney360 · 20.08.2026

DOI: 10.34067/kid.0000001325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 20.08.2026. Verfasst von Ting-Yu Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients with liver cirrhosis and end-stage kidney disease, the optimal dialysis modality remains uncertain because liver cirrhosis amplifies competing risks of infection, bleeding, and cardiovascular events.

Methods

Using the TriNetX electronic health record network, we conducted a retrospective cohort study of adults with liver cirrhosis and end-stage kidney disease initiating peritoneal dialysis or hemodialysis, matched 1:1 on 43 covariates. Follow-up began at a 30-day landmark. The primary endpoint was all-cause mortality. Secondary endpoints included peritonitis, sepsis, gastrointestinal bleeding requiring endoscopic hemostasis, and hospitalization. Composite major adverse cardiovascular events, non-fatal myocardial infarction, and non-fatal stroke were exploratory outcomes.

Results

Among 1,534 matched pairs, peritoneal dialysis was associated with lower 3-year survival (39.5% versus 46.6%; hazard ratio (HR), 1.23; 95% confidence interval (CI), 1.10 to 1.38; P < 0.001), higher risk of peritonitis (HR, 3.85; 95% CI, 2.86 to 5.19; P < 0.001) and sepsis (HR, 1.51; 95% CI, 1.23 to 1.84; P < 0.001), and more hospital admissions (mean, 4.94 versus 4.32; P = 0.02). Gastrointestinal bleeding requiring endoscopic hemostasis did not differ significantly (HR, 1.20; P = 0.38). Among exploratory cardiovascular outcomes, peritoneal dialysis was associated with higher composite major adverse cardiovascular events (HR, 1.36; 95% CI, 1.08 to 1.72; P = 0.01) and borderline higher non-fatal myocardial infarction risk (HR, 1.30; 95% CI, 1.00 to 1.69; P = 0.05), whereas non-fatal stroke did not differ significantly (HR, 1.32; P = 0.10).

Conclusions

In patients with liver cirrhosis and end-stage kidney disease, peritoneal dialysis was associated with higher mortality, greater infectious and hospitalization burden compared with hemodialysis, without a reduction in severe gastrointestinal bleeding; in exploratory analyses, peritoneal dialysis was also associated with higher composite major adverse cardiovascular events.

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei, Taiwan.
  • Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.
  • Division of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

ORCID-Profile: Ting-Yu Lin, Ming-Tsang Chuang, Wei-Yu Kao, Raymond K Hsu, Jui-Ting Chang, Yen-Chung Lin

Zitieren

APA

Lin, T. Y., Chuang, M. T., Kao, W. Y., Yeh, H. J., Hsu, R. K., Chang, J. T., & Lin, Y. C. (2026). Dialysis Modalities in Liver Cirrhosis with ESKD. Kidney360. https://doi.org/10.34067/kid.0000001325

Vancouver

Lin TY, Chuang MT, Kao WY, Yeh HJ, Hsu RK, Chang JT, et al. Dialysis Modalities in Liver Cirrhosis with ESKD. Kidney360. 2026. doi:10.34067/kid.0000001325

BibTeX
@article{Lin2026,
  author = {Lin, Ting-Yu and Chuang, Ming-Tsang and Kao, Wei-Yu and Yeh, Hsing-Jung and Hsu, Raymond K and Chang, Jui-Ting and Lin, Yen-Chung},
  title = {Dialysis Modalities in Liver Cirrhosis with ESKD},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001325}
}
Kostenlos starten →